Abbott Archives - Mediu

ID NOW™ Universal Barcode Scanner

ashbal621@gmail.com — Thu, 08 Dec 2022 04:31:19 +0000

For use with ID Now System
ID Now System provide spoint-of-care results for COVID-19 testing

Material	Description	Packaging

ALRIDSCANNER	Barcode Scanner for ID Now System	1 EA

The post ID NOW™ Universal Barcode Scanner appeared first on Mediu.

ID NOW™ Printer BOM (Includes Cable and Cord)

ashbal621@gmail.com — Thu, 08 Dec 2022 04:11:30 +0000

Qualitative detection of infectious diseases with isothermal nucleic acid amplification technology
More accurate than conventional rapid tests
Faster than other molecular methods for making effective clinical decisions sooner
Influenza A & B 2.0 test starts providing positive results in just 5 minutes, with 95% detected in 7 minutes; negative results in 13 minutes
Strep A 2.0 gives positive results in as little as 2 minutes, with 99% detected in 3 minutes; confirmatory negative results in 6 minutes

Packaging	1 Each / Each
Manufacturer	Abbott
Manufacturer #	ALEREIPRINTER

The post ID NOW™ Printer BOM (Includes Cable and Cord) appeared first on Mediu.

ID NOW™ Analyzer

ashbal621@gmail.com — Thu, 08 Dec 2022 04:03:01 +0000

Qualitative detection of infectious diseases with isothermal nucleic acid amplification technology
More accurate than conventional rapid tests
Faster than other molecular methods for making effective clinical decisions sooner
Influenza A & B 2.0 test starts providing positive results in just 5 minutes, with 95% detected in 7 minutes; negative results in 13 minutes
Strep A 2.0 gives positive results in as little as 2 minutes, with 99% detected in 3 minutes; confirmatory negative results in 6 minutes

Packaging	1 Each / Each
Manufacturer	Abbott
Manufacturer #	NAT-024

The post ID NOW™ Analyzer appeared first on Mediu.

ID NOW COVID-19 Control Swab Kit 2.0

ashbal621@gmail.com — Thu, 08 Dec 2022 03:43:24 +0000

ID NOW COVID-19 2.0 Assay is for use under an Emergency use Authorization Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
ID NOW COVID-19 2.0 assay performed on the ID NOW Instrument is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology (NAAT) intended for the qualitative detection of nucleic acid from SARS-CoV-2 in direct anterior nasal (nasal) or nasopharyngeal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform high, moderate or waived complexity tests
The ID NOW COVID-19 2.0 assay is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
Kit contains: 12 Positive / 12 Negative Swabs
Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
Positive results do not rule out bacterial infection or co-infection with other viruses
Testing facilities within the United States and its territories are required to report all results to the appropriate public health authorities
Negative results should be treated as presumptive and, if inconsistent with clinical signs and symptoms or necessary for patient management, should be confirmed with a different authorized or cleared molecular test in a CLIA-certified laboratory that meets requirements to perform high or moderate complexity tests
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions; negative results must be combined with clinical observations, patient history, and/or epidemiological information

The post ID NOW COVID-19 Control Swab Kit 2.0 appeared first on Mediu.

ID NOW™ COVID-19 2.0

ashbal621@gmail.com — Tue, 06 Dec 2022 04:04:39 +0000

POWERFUL CHOICES

With ID NOW COVID-19 2.0, you now have the power to choose to test for COVID-19 only or COVID-19 plus influenza A&B with the same patient swab.

UNCOMPROMISED PERFORMANCE

The ID NOW COVID-19 2.0 assay is a nucleic acid amplification test (NAAT) that isothermally uses nicking enzyme amplification reaction (NEAR) technology. Thus, the ID NOW COVID-19 2.0 assay provides molecular results in a fraction of the time needed by traditional molecular lab tests.

FAST DIAGNOSIS AND TREATMENT

With positive results in as few as 6 minutes and negative results in 12 minutes or less, ID NOW COVID-19 2.0 provides real-time diagnostics where and when you need them — in near-patient settings at the point of care.

SIMPLE AND SMART TECHNOLOGY

The ID NOW platform is designed with intuitive operations that guide you at every step. The assay kit does not require refrigeration and contains all the components needed so you can test on-demand, right out of the box.

Plus, the ID NOW platform easily integrates into existing patient diagnostic workflows and readily connects with hospital, laboratory, or patient information systems.

The post ID NOW™ COVID-19 2.0 appeared first on Mediu.

Determine HIV-1/2 Ag / Ab Combo Test

ashbal621@gmail.com — Wed, 23 Nov 2022 23:45:59 +0000

This 4th generation test has the ability to identify HIV sooner than conventional rapid tests which rely solely on the presence of HIV-1/2 antibodies
Built-in quality controls to let you know the test is working
Can be performed with a variety of sample types – whole blood, serum and plasma
Test strips are provided in an aluminum Ziplock pouch and can be separated from each other by tearing along the perforated lines
Each test strip has a cover that is to be removed for sample application and visualization of test results
Chase buffer included for use with whole blood samples

Kit also includes test cards, capillary tubes, disposable workstation, package insert and quick reference guideSPECIFICATIONS:

Method	Lateral Flow
Time to results	20 minutes
Results window	20-30 minutes after starting test
Test lines	HIV-1 p24 antigen HIV-1/2 antibodies
Storage conditions	2-30°C (36-86°F)
Test shelf life	24 months*
External controls shelf life	24 months**
Sample type	Wholeblood/serum/plasma
Operating temperature	15-30°C (59 to 86°F)

The post Determine HIV-1/2 Ag / Ab Combo Test appeared first on Mediu.

Abbott BinaxNOW Strep A Test

ashbal621@gmail.com — Wed, 23 Nov 2022 23:37:16 +0000

The BinaxNOW Strep A Test is as easy as 1-2-3: just three simple steps and 6 minutes to results.
A rapid immunochromatographic assay for the qualitative detection of Streptococcus pyogenes Group A antigen from throat swab specimens increase patient satisfaction with rapid information before they leave your office.
Treat your patient immediately with the appropriate therapy; no more follow-up appointments or phone calls.

SPECIFICATIONS:

Latex Free	Yes
No. of Tests	25
Type of Test	Swab
UNSPSC	41116130

The post Abbott BinaxNOW Strep A Test appeared first on Mediu.

Abbott BinaxNOW RSV Tests – Nasopharyngeal Swab

ashbal621@gmail.com — Wed, 23 Nov 2022 23:29:08 +0000

Immunochromatographic assay for the qualitative detection of RSV fusion protein antigen in neonatal and pediatric patients under the age of five

Time for test results: 15 minutes
Sample type: Nasal wash and nasopharyngeal (NP) swabs
Nasal Wash: Sensitivity 89%, Specificity 100%
NP Swabs: Sensitivity 93%, Specificity 93%
Intended for in vitro diagnostic use

SPECIFICATIONS:

Detectable Analytes	RSV
Sample Type	Nasal wash and nasopharyngeal swab
Test Time	15 min.

The post Abbott BinaxNOW RSV Tests – Nasopharyngeal Swab appeared first on Mediu.

BinaxNOW Influenza A and B Card Reader

ashbal621@gmail.com — Wed, 23 Nov 2022 23:17:39 +0000

This camera-based instrument accurately reads and
interprets lateral flow tests in just seconds
. It can detect the presence of and identify a completed
lateral flow assay, analyze the intensity of the test and
control line and display the results on the color touch
screen
. Features an easy-to-use, straight forward rapid assay
procedure
. Results are objective because they come from the
instrument, rather than a person who might interpret them
subjectively

SPECIFICATIONS:

Content And Storage	Room Temperature
CE Marker	No
Detectable Analytes	Influenza
Sample Type	Nasal and NP
Formulation	LF test card
Includes	Controls, collection swabs
Quantity	22

The post BinaxNOW Influenza A and B Card Reader appeared first on Mediu.

BinaxNow Covid-19 Antigen Self Test 2 pack

ashbal621@gmail.com — Wed, 23 Nov 2022 05:35:17 +0000

Product Details

UPC: 811877011408

Brand: BinaxNow

MPN : 195-260

UNSPSC Code: 42000000

Manufacturer: Abbott Laboratories

Weight: 0.30 lbs

Description Of Our BinaxNOW By Abbott – Rapid Antigen COVID-19 Self Test Kit OTC (2-Pack)

The BinaxNow At-home covid self test is a simple solution for COVID-19 infection detection, with rapid results in the convenience of your home. The Binaxnow covid-19 AG card test has received FDA Emergency Use Authorization for self-testing without the need to visit a healthcare professional or send samples to a laboratory. Binax Now by Abbott is a 15-minute at-home antigen that detect covid-19 it can be completed anytime, anywhere, and at any place. The test kit comes with two tests that are used 36 hours apart for better evaluation of covid symptoms. Buy in Bulk BinaxNow covid wich detects the variants of omicron BA1 to BA 5.

SIMPLE AND EASY TO USE

Requires just a shallow nasal swab that you can do yourself; includes easy-to-follow illustrated instructions.

SEE RESULTS IN 15 MINUTES

Convenient, fast results anytime, anywhere; no need for a prescription or to send to a lab.

DETECTS ACTIVE INFECTION

Designed to detect covid-19 infection with or without symptoms. Detects multiple strains including DELTA and OMICRON variants.**

The post BinaxNow Covid-19 Antigen Self Test 2 pack appeared first on Mediu.